C12N2320/10- Applications Uses in screening processes.C12N2310/20- Type of nucleic acid involving clustered regularly interspaced short palindromic repeats.C12N2310/14- Type of nucleic acid interfering N.A.C12N2310/00- Structure or type of the nucleic acid.G16B25/10- Gene or protein expression profiling Expression-ratio estimation or normalisation.G16B25/00- ICT specially adapted for hybridisation ICT specially adapted for gene or protein expression.G16B20/30- Detection of binding sites or motifs.G16B20/00- ICT specially adapted for functional genomics or proteomics, e.g.INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY G16- INFORMATION AND COMMUNICATION TECHNOLOGY SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS.ribozymes Nucleic acids used in co-suppression or gene silencing antisense oligonucleotides Antisense DNA or RNA Triplex- forming oligonucleotides Catalytic nucleic acids, e.g. C12N15/113- Non-coding nucleic acids modulating the expression of genes, e.g.C12N15/11- DNA or RNA fragments Modified forms thereof Non-coding nucleic acids having a biological activity.plasmids, or their isolation, preparation or purification Use of hosts therefor C12N15/00- Mutation or genetic engineering DNA or RNA concerning genetic engineering, vectors, e.g.

C12N- MICROORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA.C12- BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION OR GENETIC ENGINEERING.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201762501795P external-priority Application filed by Camp4 Therapeutics Corporation filed Critical Camp4 Therapeutics Corporation Priority to US16/610,899 priority Critical patent/US20210254056A1/en Publication of WO2018204764A1 publication Critical patent/WO2018204764A1/en Links Ward Original Assignee Camp4 Therapeutics Corporation Priority date (The priority date is an assumption and is not a legal conclusion. O'DONNELL Cynthia Smith Gavin WHISSELL Brett Chevalier Jennifer F. Inventor Yuting Liu Alla SIGOVA Charles W. Google Patents WO2018204764A1 - Identification and targeted modulation of gene signaling networks WO2018204764A1 - Identification and targeted modulation of gene signaling networks

Butyrfentanyl atc code